Target intelligence / Profile preview

Acetylcholine-activated inward rectifier potassium channel (GIRK)

Target
GIRK
Molecular classification
Ion channel, Inward rectifier potassium channel, G protein-coupled receptor-regulated channel
01

Overview

Acetylcholine-activated inward rectifier potassium channels, commonly known as GIRK channels, are a family of ion channels that play a critical role in regulating cellular excitability in the heart and central nervous system (UniProt: P48549, P48544). These channels are unique because they are directly gated by the G-beta-gamma subunits released from G-protein-coupled receptors, such as the M2 muscarinic and A1 adenosine receptors (IUPHAR/BPS Guide to PHARMACOLOGY). In the heart, activation of these channels by acetylcholine leads to an efflux of potassium ions, causing membrane hyperpolarization and a subsequent decrease in heart rate and atrial contractility (PubMed: 25635020). Pathologically, the constitutive activation of these channels is a key driver in the pathogenesis of atrial fibrillation, making them a significant target for anti-arrhythmic therapy (PubMed: 30135018). In the brain, GIRK channels modulate neuronal firing and are involved in the mechanisms of pain, addiction, and epilepsy. Therapeutic strategies include the development of selective blockers to treat cardiac arrhythmias and activators to manage neurological conditions, though achieving tissue specificity remains a primary therapeutic challenge.

Other names
G protein-coupled inwardly-rectifying potassium channelK_ACh channelKir3 channelG protein-activated inward rectifier potassium channelKCNJ3/KCNJ5 heterotetramer
02

Mechanism of action

Activation by G-protein beta-gamma (Gβγ) subunits following GPCR stimulation (e.g., M2 muscarinic or A1 adenosine receptors) leads to potassium efflux and membrane hyperpolarization.

03

Biological functions

Signal transductionRegulation of heart rateMembrane hyperpolarizationNeuronal excitabilitySynaptic transmissionPotassium ion transport
04

Disease associations

Atrial fibrillationArrhythmiaHypertensionEpilepsyPainDrug addictionKeppen-Lubinsky syndromePrimary aldosteronism
05

Safety considerations

BradycardiaAtrioventricular blockPro-arrhythmic riskCentral nervous system side effectsOff-target effects on other Kir channels
06

Interacting drugs

Carbachol

8 more in the full profile.

07

Biomarkers

KCNJ5 mutation statusAtrial effective refractory period (AERP)Heart rate variabilityGIRK4 expression levels

Beyond the preview

Go deeper on Acetylcholine-activated inward rectifier potassium channel (GIRK).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acetylcholine-activated inward rectifier potassium channel (GIRK).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call